Powered by

XTuit Pharmaceuticals Appoints Dr. Deborah Dunsire as President and Chief Executive Officer

Mar 8, 2017 - Business Wire
Board and Executive Moves

XTuit Pharmaceuticals , Inc., a privately-held biopharmaceutical company developing novel therapeutics targeting the disease-promoting microenvironment in fibrotic diseases and cancer, today announced the appointment of Deborah Dunsire, M.D., as president and chief executive officer. She also joins the company's board of directors. Dr. Dunsire brings more than two decades of strategic, clinical, commercial and management experience in the biotech and pharmaceutical industry. She has proven leade

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox